Evidence map›Paper›PMID 32967734›Full record

ArticleStem cell research & therapy2020

Peripheral blood-derived monocytes show neuronal properties and integration in immune-deficient rd1 mouse model upon phenotypic differentiation and induction with retinal growth factors.

Alaknanda Mishra, K Varsha Mohan, Perumal Nagarajan, Srikanth Iyer, Ashwani Kesarwani, Madhu Nath, Laxmi Moksha, Jashdeep Bhattacharjee, Barun Das, Kshama Jain and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Alaknanda MishraNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
K Varsha MohanNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Perumal NagarajanNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Srikanth IyerNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Ashwani KesarwaniNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Madhu NathDepartment of Ocular Pharmacology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India.
Laxmi MokshaDepartment of Ocular Pharmacology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India.
Jashdeep BhattacharjeeNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Barun DasNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Kshama JainNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Parul SahuNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Prakriti SinhaNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
T VelapandianDepartment of Ocular Pharmacology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India.
Pramod UpadhyayNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India. pkumar@nii.ac.in.ORCID 0000-0002-5560-822X
National Institute of Immunology · INAll India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCell therapy is one of the most promising therapeutic interventions for retinitis pigmentosa. In the current study, we aimed to assess if peripheral blood-derived monocytes which are highly abundant and accessible could be utilized as a potential candidate for phenotypic differentiation into neuron-like cells.

methodsThe peripheral blood-derived monocytes were reconditioned phenotypically using extrinsic growth factors to induce pluripotency and proliferation. The reconditioned monocytes (RM) were further incubated with a cocktail of growth factors involved in retinal development and growth to induce retinal neuron-like properties. These cells, termed as retinal neuron-like cells (RNLCs) were characterized for their morphological, molecular and functional behaviour in vitro and in vivo.

resultsThe monocytes de-differentiated in vitro and acquired pluripotency with the expression of prominent stem cell markers. Treatment of RM with retinal growth factors led to an upregulation of neuronal and retinal lineage markers and downregulation of myeloid markers. These cells show morphological alterations resembling retinal neuron-like cells and expressed photoreceptor (PR) markers. The induced RNLCs also exhibited relative membrane potential change upon light exposure suggesting that they have gained some neuronal characteristics. Further studies showed that RNLCs could also integrate in an immune-deficient retinitis pigmentosa mouse model NOD.SCID-rd1 upon sub-retinal transplantation. The RNLCs engrafted in the inner nuclear layer (INL) and ganglion cell layer (GCL) of the RP afflicted retina. Mice transplanted with RNLCs showed improvement in depth perception, exploratory behaviour and the optokinetic response.

conclusionsThis proof-of-concept study demonstrates that reconditioned monocytes can be induced to acquire retinal neuron-like properties through differentiation using a defined growth media and can be a potential candidate for cell therapy-based interventions and disease modelling for ocular diseases.

Indexed as

MonocytesRetinaAnimalsCell DifferentiationMiceMice, Inbred NODMice, SCIDNeuronsHuman peripheral blood monocytesrd1 mouse modelRetinal neuron-like cellsRetinitis pigmentosaVisual activity

Identifiers

PMID32967734
PMCPMC7510317
OpenAlexW3088237585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.